{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:47:26Z","timestamp":1761490046518},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s11239-016-1395-7","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T14:53:29Z","timestamp":1467730409000},"page":"586-592","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients"],"prefix":"10.1007","volume":"42","author":[{"given":"Giulia","family":"Berti de Marinis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Novello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Barzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Cortella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Businaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"issue":"6","key":"1395_CR1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. canadian apheresis study group. N Engl J Med 325(6):393\u2013397","journal-title":"N Engl J Med"},{"issue":"5","key":"1395_CR2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","volume":"142","author":"M Scully","year":"2008","unstructured":"Scully M, Yarranton H, Liesner R, Cavenagh J, Hunt B, Benjamin S et al (2008) Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 142(5):819\u2013826","journal-title":"Br J Haematol"},{"issue":"22","key":"1395_CR3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339(22):1578\u20131584","journal-title":"N Engl J Med"},{"issue":"22","key":"1395_CR4","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339(22):1585\u20131594","journal-title":"N Engl J Med"},{"issue":"6855","key":"1395_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413(6855):488\u2013494","journal-title":"Nature"},{"issue":"11","key":"1395_CR6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2362.2012.02710.x","volume":"42","author":"AM Lombardi","year":"2012","unstructured":"Lombardi AM, Fabris R, Scarda A, Zanato V, Dal Pr\u00e0 C, Scarparo P et al (2012) Presence of anti-ADAMTS13 antibodies in obesity. Eur J Clin Invest 42(11):1197\u20131204","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"1395_CR7","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","volume":"102","author":"F Scheiflinger","year":"2003","unstructured":"Scheiflinger F, Kn\u00f6bl P, Trattner B, Plaimauer B, Mohr G, Dockal M et al (2003) Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Blood 102(9):3241\u20133243","journal-title":"Blood"},{"issue":"9","key":"1395_CR8","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1538-7836.2008.03099.x","volume":"6","author":"A Tripodi","year":"2008","unstructured":"Tripodi A, Peyvandi F, Chantarangkul V, Palla R, Afrasiabi A, Canciani MT et al (2008) Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). J Thromb Haemost 6(9):1534\u20131541","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1395_CR9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5858\/arpa.2013-0170-OA","volume":"138","author":"BD Barrows","year":"2014","unstructured":"Barrows BD, Teruya J (2014) Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura. Arch Pathol Lab Med 138(4):546\u2013549","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"1395_CR10","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","volume":"98","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E (2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98(9):2730\u20132735","journal-title":"Blood"},{"issue":"6","key":"1395_CR11","first-page":"1320","volume":"92","author":"A S\u00e1nchez-Luceros","year":"2004","unstructured":"S\u00e1nchez-Luceros A, Far\u00edas CE, Amaral MM, Kempfer AC, Votta R, Marchese C et al (2004) von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 92(6):1320\u20131326","journal-title":"Thromb Haemost"},{"issue":"1","key":"1395_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","volume":"102","author":"SK Vesely","year":"2003","unstructured":"Vesely SK, George JN, L\u00e4mmle B, Studt JD, Alberio L, El-Harake MA et al (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102(1):60\u201368","journal-title":"Blood"},{"issue":"1","key":"1395_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/trf.12885","volume":"55","author":"JN George","year":"2015","unstructured":"George JN (2015) Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why? Transfusion 55(1):11\u201313","journal-title":"Transfusion"},{"key":"1395_CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","volume":"129","author":"K Kokame","year":"2005","unstructured":"Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T (2005) FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129:93\u2013100","journal-title":"Br J Haematol"},{"key":"1395_CR15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bjh.13658","volume":"171","author":"PK Bendapudi","year":"2015","unstructured":"Bendapudi PK, Li A, Hamdan A, Uhl L, Kaufman R, Stowell C et al (2015) Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the harvard TMA research collaborative. Br J Haematol 171:836\u2013844","journal-title":"Br J Haematol"},{"issue":"4","key":"1395_CR16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjh.12569","volume":"163","author":"N Shah","year":"2013","unstructured":"Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R (2013) Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol 163(4):514\u2013519","journal-title":"Br J Haematol"},{"issue":"8","key":"1395_CR17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","volume":"115","author":"Kremer Hovinga JA","year":"2010","unstructured":"Kremer Hovinga JA (2010) Vesely SK, Terrell DR, L\u00e4mmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 115(8):1500\u20131511","journal-title":"Blood"},{"issue":"11","key":"1395_CR18","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.2215\/CJN.01700215","volume":"10","author":"E Rurali","year":"2015","unstructured":"Rurali E, Banterla F, Donadelli R, Bresin E, Galbusera M, Gastoldi S, Peyvandi F, Underwood M, Remuzzi G, Noris M (2015) ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment. Clin J Am Soc Nephrol 10(11):2002\u20132012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1395_CR19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.12826","volume":"13","author":"L Zafrani","year":"2015","unstructured":"Zafrani L, Mariotte E, Darmon M, Canet E, Merceron S, Boutboul D, Veyradier A, Galicier L, Azoulay E (2015) Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost 13(3):380\u2013389","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1395_CR20","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","volume":"5","author":"P Coppo","year":"2010","unstructured":"Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C et al (2010) Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One 5(4):e10208","journal-title":"PLoS One"},{"issue":"3","key":"1395_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F et al (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158(3):323\u2013335","journal-title":"Br J Haematol"},{"issue":"6","key":"1395_CR22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/ejh.12273","volume":"92","author":"AM Lombardi","year":"2014","unstructured":"Lombardi AM, Fabris R, de Marinis GB, Marson P, Navaglia F, Plebani M, Vettor R, Fabris F (2014) Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura. Eur J Haematol 92(6):497\u2013501","journal-title":"Eur J Haematol"},{"issue":"1","key":"1395_CR23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1538-7836.2011.04548.x","volume":"10","author":"S Ferrari","year":"2012","unstructured":"Ferrari S, Kn\u00f6bl P, Kolovratova V, Plaimauer B, Turecek PL, Varadi K, Rottensteiner H, Scheiflinger F (2012) Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost 10(1):156\u2013158","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1395-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:51:30Z","timestamp":1498326690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1395-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1395-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,5]]}}}